Item talk:Q166750: Difference between revisions
From geokb
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | { | ||
" | "OpenAlex": { | ||
"display_name": "Statistical Methods in Clinical Trials and Drug Development", | |||
"description": "This cluster of papers covers a wide range of statistical methods and design considerations in the context of clinical trials and drug development. It includes topics such as controlling the false discovery rate, adaptive trial designs, noninferiority trials, biomarkers, phase I trials, multiple testing, Bayesian methods, sample size determination, composite endpoints, and pharmacokinetic/pharmacodynamic modeling.", | |||
"keywords": [ | |||
"False Discovery Rate", | |||
"Adaptive Designs", | |||
"Noninferiority Trials", | |||
"Biomarkers", | |||
"Phase I Trials", | |||
"Multiple Testing", | |||
"Bayesian Methods", | |||
"Sample Size", | |||
"Composite Endpoints", | |||
"Pharmacokinetic/Pharmacodynamic Modeling" | |||
], | |||
"ids": { | |||
"openalex": "https://openalex.org/T11235", | |||
"wikipedia": "https://en.wikipedia.org/wiki/Clinical_trial" | |||
}, | }, | ||
{ | "subfield": { | ||
"id": "https://openalex.org/ | "id": "https://openalex.org/subfields/2613", | ||
"display_name": " | "display_name": "Statistics and Probability" | ||
}, | }, | ||
{ | "field": { | ||
"id": "https://openalex.org/ | "id": "https://openalex.org/fields/26", | ||
"display_name": " | "display_name": "Mathematics" | ||
}, | }, | ||
{ | "domain": { | ||
"id": "https://openalex.org/ | "id": "https://openalex.org/domains/3", | ||
"display_name": " | "display_name": "Physical Sciences" | ||
}, | }, | ||
"updated_date": "2024-08-12T06:08:49.896735", | |||
"created_date": "2024-01-23", | |||
"type": "topic", | |||
"oa_id": "T11235", | |||
"id": "https://openalex.org/T11235" | |||
} | |||
} | } |
Latest revision as of 20:51, 12 September 2024
{
"OpenAlex": { "display_name": "Statistical Methods in Clinical Trials and Drug Development", "description": "This cluster of papers covers a wide range of statistical methods and design considerations in the context of clinical trials and drug development. It includes topics such as controlling the false discovery rate, adaptive trial designs, noninferiority trials, biomarkers, phase I trials, multiple testing, Bayesian methods, sample size determination, composite endpoints, and pharmacokinetic/pharmacodynamic modeling.", "keywords": [ "False Discovery Rate", "Adaptive Designs", "Noninferiority Trials", "Biomarkers", "Phase I Trials", "Multiple Testing", "Bayesian Methods", "Sample Size", "Composite Endpoints", "Pharmacokinetic/Pharmacodynamic Modeling" ], "ids": { "openalex": "https://openalex.org/T11235", "wikipedia": "https://en.wikipedia.org/wiki/Clinical_trial" }, "subfield": { "id": "https://openalex.org/subfields/2613", "display_name": "Statistics and Probability" }, "field": { "id": "https://openalex.org/fields/26", "display_name": "Mathematics" }, "domain": { "id": "https://openalex.org/domains/3", "display_name": "Physical Sciences" }, "updated_date": "2024-08-12T06:08:49.896735", "created_date": "2024-01-23", "type": "topic", "oa_id": "T11235", "id": "https://openalex.org/T11235" }
}